Rapport Therapeutics, Inc. Common Stock (RAPP) ownership: Top institutional holder: FMR LLC ($224.32M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 7168939.00 | $224.32M | 2026-03-31 |
| TRV GP V, LLC | 7135233.00 | $223.26M | 2026-03-31 |
| ARCH Venture Management, LLC | 3728738.00 | $116.67M | 2026-03-31 |
| Capital International Investors | 3097973.00 | $96.94M | 2026-03-31 |
| Cormorant Asset Management, LP | 2957521.00 | $92.54M | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 2942251.00 | $92.06M | 2026-03-31 |
| BlackRock, Inc. | 2505955.00 | $78.41M | 2026-03-31 |
| Sofinnova Investments, Inc. | 1904408.00 | $59.59M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-04-17 | |
| Sell | null | 2026-04-14 | |
| Sell | null | 2026-04-13 | |
| Sell | null | 2026-04-10 | |
| Sell | null | 2026-04-08 | |
| Sell | null | 2026-03-30 | |
| Sell | null | 2026-03-30 | |
| Sell | null | 2026-03-25 |
Back to RAPP overview · RAPP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.